최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of pharmaceutical analysis = 藥物分析學報 (英文版), v.10 no.2, 2020년, pp.102 - 108
Li, Xiaowei (Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center) , Geng, Manman (Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center) , Peng, Yizhao (Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center) , Meng, Liesu (Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center) , Lu, Shemin (Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center)
Abstract Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the sev...
1 Zhou P. Yang X.L. Wang X.G. A?pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 2020 10.1038/s41586-020-2012-7
2 de Wit E. van Doremalen N. Falzarano D. SARS and MERS: recent insights into emerging coronaviruses Nat. Rev. Microbiol. 14 2016 523 534 10.1038/nrmicro.2016.81 27344959
3 Wu J.T. Leung K. Leung G.M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Lancet 2020 10.1016/S0140-6736(20)30260-9
4 Su S. Wong G. Shi W. Epidemiology, Genetic recombination, and pathogenesis of coronaviruses Trends Microbiol. 24 2016 490 502 10.1016/j.tim.2016.03.003 27012512
5 Perlman S. J.?Netland Coronaviruses post-SARS: update on replication and pathogenesis Nat. Rev. Microbiol. 7 2009 439 450 10.1038/nrmicro2147 19430490
6 Lu R. Zhao X. Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Lancet 2020 10.1016/S0140-6736(20)30251-8
8 Masters P.S. The molecular biology of coronaviruses Adv. Virus Res. 66 2006 193 292 10.1016/S0065-3527(06)66005-3 16877062
9 Knoops K. Kikkert M. Worm S.H. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum PLoS Biol. 6 2008 10.1371/journal.pbio.0060226 e226
10 Li W. Moore M.J. Vasilieva N. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454 10.1038/nature02145 14647384
11 Ge X.Y. Li J.L. Yang X.L. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Nature 503 2013 535 538 10.1038/nature12711 24172901
12 Chinese SARS Molecular Epidemiology Consortium Chinese Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China Science 303 2004 1666 1669 10.1126/science.1092002 14752165
13 Raj V.S. Mou H. Smits S.L. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature 495 2013 251 254 10.1038/nature12005 23486063
14 Barlan A. Zhao J. Sarkar M.K. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection J.?Virol. 88 2014 4953 4961 10.1128/JVI.00161-14 24554656
15 Huang C. Wang Y. Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020 10.1016/S0140-6736(20)30183-5
16 Peiris J.S. Guan Y. Yuen K.Y. Severe acute respiratory syndrome Nat. Med. 10 2004 S88 S97 10.1038/nm1143 15577937
17 Wu F. Zhao S. Yu B. A?new coronavirus associated with human respiratory disease in China Nature 2020 10.1038/s41586-020-2008-3
18 Jeffers S.A. Tusell S.M. Gillim-Ross L. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus Proc. Natl. Acad. Sci. U.S.A. 1 01 2004 15748 15753 10.1073/pnas.0403812101 15496474
19 Simmons G. Reeves J.D. Rennekamp A.J. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry Proc. Natl. Acad. Sci. U.S.A. 101 2004 4240 4245 10.1073/pnas.0306446101 15010527
20 Belouzard S. Chu V.C. Whittaker G.R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites Proc. Natl. Acad. Sci. U.S.A. 106 2009 5871 5876 10.1073/pnas.0809524106 19321428
21 Millet J.K. Whittaker G.R. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein Proc. Natl. Acad. Sci. U.S.A. 111 2014 15214 15219 10.1073/pnas.1407087111 25288733
22 Wang H. Yang P. Liu K. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway Cell Res. 18 2008 290 301 10.1038/cr.2008.15 18227861
23 Kuba K. Imai Y. Ohto-Nakanishi T. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters Pharmacol. Ther. 128 2010 119 128 10.1016/j.pharmthera.2010.06.003 20599443
24 Liu J. Wu P. Gao F. Novel immunodominant peptide presentation strategy: a featured HLA-A?2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein J.?Virol. 84 2010 11849 11857 10.1128/JVI.01464-10 20844028
25 Keicho N. Itoyama S. Kashiwase K. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population Hum. Immunol. 70 2009 527 531 10.1016/j.humimm.2009.05.006 19445991
26 Chen Y.M. Liang S.Y. Shih Y.P. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003 J.?Clin. Microbiol. 44 2006 359 365 10.1128/JCM.44.2.359-365.2006 16455884
27 Wang S.F. Chen K.H. Chen M. Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection Viral Immunol. 24 2011 421 426 10.1089/vim.2011.0024 21958371
28 Hajeer A.H. Balkhy H. Johani S. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection Ann. Thorac. Med. 11 2016 211 213 10.4103/1817-1737.185756 27512511
29 Tu X. Chong W.P. Zhai Y. Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection J.?Infect. 71 2015 101 109 10.1016/j.jinf.2015.03.006 25818534
30 Li G. Chen X. Xu A. Profile of specific antibodies to the SARS-associated coronavirus N.?Engl. J. Med. 349 2003 508 509 10.1056/NEJM200307313490520 12890855
31 Xu Z. Shi L. Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Resp. Med. 2020 10.1016/S2213-2600(20)30076-X
32 Fan Y.Y. Huang Z.T. Li L. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection Arch. Virol. 154 2009 1093 1099 10.1007/s00705-009-0409-6 19526193
33 Tang F. Quan Y. Xin Z.T. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study J.?Immunol. 186 2011 7264 7268 10.4049/jimmunol.0903490 21576510
34 Zhao J. Li K. Wohlford-Lenane C. Rapid generation of a mouse model for Middle East respiratory syndrome Proc. Natl. Acad. Sci. U.S.A. 111 2014 4970 4975 10.1073/pnas.1323279111 24599590
35 Williams A.E. Chambers R.C. The mercurial nature of neutrophils: still an enigma in ARDS? Am. J. Physiol. Lung Cell Mol. Physiol. 306 2014 L217 L230 10.1152/ajplung.00311.2013 24318116
36 Channappanavar R. Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology Semin. Immunopathol. 39 2017 529 539 10.1007/s00281-017-0629-x 28466096
37 Cameron M.J. Bermejo-Martin J.F. Danesh A. Human immunopathogenesis of severe acute respiratory syndrome (SARS) Virus Res. 133 2008 13 19 10.1016/j.virusres.2007.02.014 17374415
38 Min C.K. Cheon S. Ha N.Y. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity Sci. Rep. 6 2016 25359 10.1038/srep25359 27146253
39 Snijder E.J. van der Meer Y. Zevenhoven-Dobbe J. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex J.?Virol. 80 2006 5927 5940 10.1128/JVI.02501-05 16731931
40 Channappanavar R. Fehr A.R. Vijay R. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Cell Host Microbe 19 2016 181 193 10.1016/j.chom.2016.01.007 26867177
41 Channappanavar R. Fehr A.R. Zheng J. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes J.?Clin. Invest. 130 2019 3625 3639 10.1172/JCI126363 31355779
42 Niemeyer D. Zillinger T. Muth D. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist J.?Virol. 87 2013 12489 12495 10.1128/JVI.01845-13 24027320
43 Yang Y. Zhang L. Geng H. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists Protein Cell 4 2013 951 961 10.1007/s13238-013-3096-8 24318862
44 Menachery V.D. Schafer A. Burnum-Johnson K.E. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape Proc. Natl. Acad. Sci. U.S.A. 115 2018 E1012 E1021 10.1073/pnas.1706928115 29339515
45 Corman V.M. Landt O. Kaiser M. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Euro Surveill. 25 2020 10.2807/1560-7917.ES.2020.25.3.2000045
46 Chu D.K.W. Pan Y. Cheng S.M.S. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia Clin. Chem. 2020 10.1093/clinchem/hvaa029
47 To K.K. Tsang O.T. Chik-Yan Yip C. Consistent detection of 2019 novel coronavirus in saliva Clin. Infect. Dis. 2020 10.1093/cid/ciaa149
48 Woo P.C. Lau S.K. Wong B.H. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia J.?Clin. Microbiol. 43 2005 3054 3058 10.1128/JCM.43.7.3054-3058.2005 16000415
49 Xie X. Zhong Z. Zhao W. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing Radiology 2020 200343 10.1148/radiol.2020200343
50 Yam W.C. Chan K.H. Poon L.L. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus J.?Clin. Microbiol. 41 2003 4521 4524 10.1128/jcm.41.10.4521-4524.2003 14532176
51 Pan Y. Guan H. Zhou S. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China Eur. Radiol. 2020 10.1007/s00330-020-06731-x
52 Shi H. Han X. Zheng C. Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China Radiology 2020 200269 10.1148/radiol.2020200269
53 Chung M. Bernheim A. Mei X. CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiology 2020 200230 10.1148/radiol.2020200230
54 Ooi G.C. Khong P.L. Muller N.L. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients Radiology 230 2004 836 844 10.1148/radiol.2303030853 14990845
55 Ajlan A.M. Ahyad R.A. Jamjoom L.G. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings AJR Am. J. Roentgenol. 203 2014 782 787 10.2214/AJR.14.13021 24918624
56 Zumla A. Chan J.F. Azhar E.I. Coronaviruses - drug discovery and therapeutic options Nat. Rev. Drug Discov. 15 2016 327 347 10.1038/nrd.2015.37 26868298
57 Groneberg D.A. Hilgenfeld R. Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS) Respir. Res. 6 2005 8 10.1186/1465-9921-6-8 15661082
58 Lo M.K. Jordan R. Arvey A. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses Sci. Rep. 7 2017 43395 10.1038/srep43395 28262699
59 Sheahan T.P. Sims A.C. Leist S.R. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Nat. Commun. 11 2020 222 10.1038/s41467-019-13940-6 31924756
60 de Wit E. Feldmann F. Cronin J. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection Proc. Natl. Acad. Sci. U.S.A. 2020 10.1073/pnas.1922083117
61 Lo M.K. Feldmann F. Gary J.M. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge Sci. Transl. Med. 11 2019 10.1126/scitranslmed.aau9242
62 Holshue M.L. DeBolt C. Lindquist S. First case of 2019 novel coronavirus in the United States N.?Engl. J. Med. 2020 10.1056/NEJMoa2001191
63 Wang M. Cao R. Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in?vitro Cell Res. 2020 10.1038/s41422-020-0282-0
64 De Clercq E. New nucleoside analogues for the treatment of hemorrhagic fever virus infections Chem. Asian J. 14 2019 3962 3968 10.1002/asia.201900841 31389664
65 Chen Y. Liu Q. Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis J.?Med. Virol. 92 2020 418 423 10.1002/jmv.25681 31967327
66 Chen L. Gui C. Luo X. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in?vitro J.?Virol. 79 2005 7095 7103 10.1128/JVI.79.11.7095-7103.2005 15890949
67 Jo S. Kim S. Shin D.H. Inhibition of SARS-CoV 3CL protease by flavonoids J.?Enzym. Inhib. Med. Chem. 35 2020 145 151 10.1080/14756366.2019.1690480
68 Park J.Y. Jeong H.J. Kim J.H. Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus Biol. Pharm. Bull. 35 2012 2036 2042 10.1248/bpb.b12-00623 22971649
69 Mair-Jenkins J. Saavedra-Campos M. Baillie J.K. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis J.?Infect. Dis. 211 2015 80 90 10.1093/infdis/jiu396 25030060
70 Koenig K.L. Identify-Isolate-Inform: a modified tool for initial detection and management of Middle East Respiratory Syndrome patients in the emergency department West. J. Emerg. Med. 16 2015 619 624 10.5811/westjem.2015.7.27915 26587081
71 Tian X. Li C. Huang A. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody Emerg. Microb. Infect. 9 2020 382 385 10.1080/22221751.2020.1729069
72 Zhang L. Liu Y. Potential interventions for novel coronavirus in China: a systematic review J.?Med. Virol. 2020 10.1002/jmv.25707
73 Graham R.L. Donaldson E.F. Baric R.S. A?decade after SARS: strategies for controlling emerging coronaviruses Nat. Rev. Microbiol. 11 2013 836 848 10.1038/nrmicro3143 24217413
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.